A Health-Care System Perspective on Implementing Genomic Medicine: Pediatric Acute Lymphoblastic Leukemia as a Paradigm

Clinical Pharmacology and Therapeutics - United States
doi 10.1038/clpt.2013.9
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pediatric Acute Lymphoblastic Leukemia

Hematology & Transfusion International Journal
2017English

Genomic Characterization of Childhood Acute Lymphoblastic Leukemia

Seminars in Hematology
Hematology
2013English

Challenges in Implementing Individualized Medicine Illustrated by Antimetabolite Therapy of Childhood Acute Lymphoblastic Leukemia

Clinical Proteomics
2011English

a Novel AGGF1-PDGFRb Fusion in Pediatric T-Cell Acute Lymphoblastic Leukemia

Haematologica
Hematology
2017English

Germline Genomic Variants Associated With Childhood Acute Lymphoblastic Leukemia

Nature Genetics
Genetics
2009English

Targeting the Thioredoxin System as a Novel Strategy Against B Cell Acute Lymphoblastic Leukemia

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Integrin Alpha4 as a Therapeutic Target of Acute Lymphoblastic Leukemia

Journal of Blood Disorders & Transfusion
2014English

An Oncologist’s Perspective on Metformin Use and Acute Lymphoblastic Leukemia Outcomes

Journal of Pharmacy Practice
PharmacologyPharmacy
2015English

A Perspective on the Health Care Expenditures for Defensive Medicine

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy